NCT07422233CompletedPhase 4
Evaluation of Levetiracetam's Effectiveness and Tolerability for Treating Epilepsy in Older Adults
Investigation of Efficacy and Tolerability of Levetiracetam for Epilepsy in Elderly
Source: ClinicalTrials.gov · Last updated 19 Feb 2026
Brief summary (registry, in English)
This prospective interventional study was conducted between 2023 and 2025 at the Department of Neurology of Bouali Sina Hospital. Consecutive elderly patients presenting with epilepsy were screened for eligibility. The diagnosis of epilepsy was confirmed by the treating neurologist. The patients underwent treatment with levetiracetam. Primary and secondary outcomes were investigated as was explained before.
- Status (registry)
- Completed
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 137 (actual)
- First submitted
- 5 Feb 2026
- Start date
- 13 Sept 2023
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- Nasim Tabrizi
- Diseases
- Epilepsy
- NCT number
- NCT07422233
What you commit to
- Study type: Interventional · Phase 4
- Participants enrolled: 137
- From 13 Sept 2023 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current use of antiseizure medications for any reason
Other illness
- Chronic kidney disease requiring dialysis
- History of psychotic disorders or current use of anxiolytic, antidepressant, or antipsychotic medications
Who the study is looking for
- Age ≥60 years
- Diagnosis of epilepsy
Age in the registry: 60 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mazandaran University of medical sciences Coordinator of this site? Confirm its status | Sari | Iran | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.